Quanterix (NASDAQ:QTRX) Shares Up 7.5%
Quanterix Corp (NASDAQ:QTRX) shares were up 7.5% on Wednesday . The stock traded as high as $26.49 and last traded at $26.01, approximately 188,938 shares traded hands during mid-day trading. An increase of 34% from the average daily volume of 140,747 shares. The stock had previously closed at $24.20.
A number of brokerages have recently weighed in on QTRX. ValuEngine cut shares of Quanterix from a “buy” rating to a “hold” rating in a research report on Tuesday, August 6th. BTIG Research set a $35.00 price target on shares of Quanterix and gave the company a “buy” rating in a report on Wednesday, August 7th. Canaccord Genuity restated a “buy” rating and issued a $38.00 price objective on shares of Quanterix in a research report on Wednesday, July 24th. Finally, Zacks Investment Research downgraded Quanterix from a “hold” rating to a “sell” rating in a research note on Wednesday, July 10th.
The firm has a fifty day simple moving average of $27.52 and a 200-day simple moving average of $26.60. The company has a market capitalization of $582.82 million, a P/E ratio of -18.19 and a beta of 1.33. The company has a quick ratio of 4.91, a current ratio of 5.43 and a debt-to-equity ratio of 0.10.
In other news, Director Marijn E. Dekkers sold 89,759 shares of the stock in a transaction on Tuesday, August 20th. The shares were sold at an average price of $13.63, for a total transaction of $1,223,415.17. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO E Kevin Hrusovsky sold 3,362 shares of the firm’s stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $25.97, for a total transaction of $87,311.14. The disclosure for this sale can be found here. Over the last three months, insiders have sold 105,272 shares of company stock valued at $1,694,542. 30.80% of the stock is owned by company insiders.
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Alambic Investment Management L.P. bought a new position in Quanterix during the 1st quarter worth about $353,000. BNP Paribas Arbitrage SA boosted its position in shares of Quanterix by 5,803.2% during the first quarter. BNP Paribas Arbitrage SA now owns 1,830 shares of the company’s stock worth $47,000 after buying an additional 1,799 shares during the period. GSA Capital Partners LLP acquired a new position in shares of Quanterix during the second quarter worth about $423,000. Allianz Asset Management GmbH grew its holdings in shares of Quanterix by 52.4% during the second quarter. Allianz Asset Management GmbH now owns 316,131 shares of the company’s stock worth $10,682,000 after buying an additional 108,647 shares in the last quarter. Finally, EAM Global Investors LLC bought a new position in shares of Quanterix during the first quarter worth about $1,349,000. 60.94% of the stock is currently owned by institutional investors and hedge funds.
Quanterix Company Profile (NASDAQ:QTRX)
Quanterix Corporation, a life sciences company, develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Simoa HD-1 instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids.
Read More: How a Back-End Load Mutual Fund Works
Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter.